Precision medicine solutions help you get to market efficiently and effectively.
Full spectrum support
Insights. Data. Diagnostics. Results.
Quest Companion Diagnostics supports you through all phases of precision medicine, from assay development to commercial launch and post-launch analytic capabilities. Our breadth of experience and expertise offers pharmaceutical organizations an unparalleled opportunity to target new therapies to the right patient population.
We leverage powerful insights, reliable data, efficient diagnostics, and rapid results to help accelerate the time to market. Together, we can develop the precise testing and therapies that can provide new hope to patients and their families.
Your collaborative partner
Creating comprehensive solutions together
We can collaborate with you to create a comprehensive solution—from idea to launch of a companion diagnostic, or a targeted therapy test to target your drug to the right patient population. Together we can drive the shift from the traditional “one size fits all” approach to a patient-centric care model that improves outcomes and can reduce costs.
Test development, biomarker identification to support FDA approval, commercialization, and commercialization of companion diagnostics
Pre-launch medical communications
Clinical trial wrap-around services
Day 1 ready lab for new CDx test launches
Data analytics support for targeted therapies
Assay development, validation, and scale-up
Custom testing services and targeted therapy test development
Let’s get granular
Quest analytics bring precision medicine to life
Quest Diagnostic’s highly specific diagnostic tests can help to avoid unnecessary follow-up testing and allow more accurate interpretation of depth of response to treatment. We have several successful ongoing projects with major pharmaceutical companies. Some of our work includes:
- A new class of drugs, such as “checkpoint inhibitors,” which were recently approved by the FDA
- Personalized medicine
We also offer molecular testing to understand mutation status in diseases such as non–small cell lung cancer.
We offer more than 15+ years of longitudinal lab data, representing more than 58+ billion data points.
Put Quest Pharma Solutions to work for you